{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:15:05Z","timestamp":1780316105655,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012309","name":"Royal Golden Jubilee (RGJ) Ph.D. Programme","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012309","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010724","name":"Health Systems Research Institute","doi-asserted-by":"publisher","award":["65-040"],"award-info":[{"award-number":["65-040"]}],"id":[{"id":"10.13039\/501100010724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010724","name":"Health Systems Research Institute","doi-asserted-by":"publisher","award":["64-125"],"award-info":[{"award-number":["64-125"]}],"id":[{"id":"10.13039\/501100010724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The spectra of underlying genetic variants for various clinical entities including focal segmental glomerulosclerosis (FSGS) vary among different populations. Here we described the clinical and genetic characteristics of biopsy-proven FSGS patients in Thailand. Patients with FSGS pathology, without secondary causes, were included in our study. Clinical laboratory and pathological data were collected. Whole-exome sequencing (WES) was subsequently performed. 53 unrelated FSGS patients were recruited. 35 patients were adults (66.0%), and 51 patients were sporadic cases (96.2%). Clinical diagnosis before kidney biopsy was steroid-resistant nephrotic syndrome (SRNS) in 58.5%, and proteinuric chronic kidney disease in 32.1%. Using WES, disease-associated pathogenic\/likely pathogenic (P\/LP) variants could be identified in six patients including the two familial cases, making the P\/LP detection rate of 11.3% (6\/53). Of these six patients, two patients harbored novel variants with one in the <jats:italic>COL4A4<\/jats:italic> gene and one in the <jats:italic>MAFB<\/jats:italic> gene. Four other patients carried previously reported variants in the <jats:italic>CLCN5<\/jats:italic>, <jats:italic>LMX1B,<\/jats:italic> and <jats:italic>COL4A4<\/jats:italic> genes. Four of these patients (4\/6) received immunosuppressive medications as a treatment for primary FSGS before genetic diagnosis. All four did not respond to the medications, emphasizing the importance of genetic testing to avoid unnecessary treatment. Notably, the mutation detection rates in adult and pediatric patients were almost identical, at 11.4% and 11.1%, respectively. In conclusion, the overall P\/LP variant detection rate by WES in biopsy-proven FSGS patients was 11.3%. The most identified variants were in <jats:italic>COL4A4<\/jats:italic>. In addition, three novel variants associated with FSGS were detected.<\/jats:p>","DOI":"10.1038\/s41598-022-26291-y","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T11:05:15Z","timestamp":1673867115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pathogenic variant detection rate by whole exome sequencing in Thai patients with biopsy-proven focal segmental glomerulosclerosis"],"prefix":"10.1038","volume":"13","author":[{"given":"Suramath","family":"Isaranuwatchai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankanee","family":"Chanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chupong","family":"Ittiwut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rungnapa","family":"Ittiwut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chalurmpon","family":"Srichomthong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vorasuk","family":"Shotelersuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanya","family":"Suphapeetiporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kearkiat","family":"Praditpornsilpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"issue":"Suppl 4","key":"26291_CR1","first-page":"S305","volume":"88","author":"T Kanjanabuch","year":"2005","unstructured":"Kanjanabuch, T. et al. Etiologies of glomerular diseases in Thailand: a renal biopsy study of 506 cases. J. Med. Assoc. Thai. 88(Suppl 4), S305-311 (2005).","journal-title":"J. Med. Assoc. Thai."},{"key":"26291_CR2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2215\/CJN.05960616","volume":"12","author":"AZ Rosenberg","year":"2017","unstructured":"Rosenberg, A. Z. & Kopp, J. B. Focal segmental glomerulosclerosis. Clin. J. Am. Soc. Nephrol. 12, 502\u2013517 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"26291_CR3","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int. Suppl. 2, 139\u2013274 (2012)."},{"key":"26291_CR4","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/ndt\/gfv325","volume":"31","author":"C Gast","year":"2016","unstructured":"Gast, C. et al. Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis. Nephrol. Dial Transplant. 31, 961\u2013970 (2016).","journal-title":"Nephrol. Dial Transplant."},{"key":"26291_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2215\/CJN.08750718","volume":"14","author":"T Yao","year":"2019","unstructured":"Yao, T. et al. Integration of genetic testing and pathology for the diagnosis of adults with FSGS. Clin. J. Am. Soc. Nephrol. 14, 213\u2013223 (2019).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"26291_CR6","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.mayocp.2021.01.037","volume":"96","author":"J Miao","year":"2021","unstructured":"Miao, J. et al. Identification of genetic causes of focal segmental glomerulosclerosis increases with proper patient selection. Mayo Clin. Proc. 96, 2342\u20132353 (2021).","journal-title":"Mayo Clin. Proc."},{"key":"26291_CR7","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 100, S1\u2013S276 (2021)."},{"key":"26291_CR8","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.2215\/CJN.05260610","volume":"6","author":"S Sant\u00edn","year":"2011","unstructured":"Sant\u00edn, S. et al. Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 6, 1139\u20131148 (2011).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"26291_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1681\/ASN.2017090958","volume":"29","author":"AS De Vriese","year":"2018","unstructured":"De Vriese, A. S., Sethi, S., Nath, K. A., Glassock, R. J. & Fervenza, F. C. Differentiating primary, genetic, and secondary FSGS in adults: A Clinicopathologic Approach. J. Am. Soc. Nephrol. 29, 759\u2013774 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"26291_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1053\/snep.2003.50012","volume":"23","author":"V D'Agati","year":"2003","unstructured":"D\u2019Agati, V. Pathologic classification of focal segmental glomerulosclerosis. Semin. Nephrol. 23, 117\u2013134 (2003).","journal-title":"Semin. Nephrol."},{"key":"26291_CR11","doi-asserted-by":"crossref","unstructured":"Richards, S., Aziz, N., Bale, S., et al. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u201324 (2015).","DOI":"10.1038\/gim.2015.30"},{"key":"26291_CR12","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41431-021-00858-1","volume":"29","author":"J Savige","year":"2021","unstructured":"Savige, J. et al. Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria. Eur. J. Hum. Genet. 29, 1186\u20131197 (2021).","journal-title":"Eur. J. Hum. Genet."},{"key":"26291_CR13","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00467-018-3985-4","volume":"34","author":"J Savige","year":"2019","unstructured":"Savige, J. et al. Expert consensus guidelines for the genetic diagnosis of Alport syndrome. Pediatr. Nephrol. 34, 1175\u20131189 (2019).","journal-title":"Pediatr. Nephrol."},{"key":"26291_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/humu.22804","volume":"36","author":"L Mansour-Hendili","year":"2015","unstructured":"Mansour-Hendili, L. et al. Mutation update of the CLCN5 gene responsible for Dent disease 1. Hum. Mutat. 36, 743\u2013752 (2015).","journal-title":"Hum. Mutat."},{"key":"26291_CR15","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1681\/ASN.2013020171","volume":"24","author":"O Boyer","year":"2013","unstructured":"Boyer, O. et al. LMX1B mutations cause hereditary FSGS without extrarenal involvement. J. Am. Soc. Nephrol. 24, 1216\u20131222 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"26291_CR16","doi-asserted-by":"crossref","unstructured":"Gibson, J., Fieldhouse, R., & Chan, M. M. Y., et al. Genomics England Research Consortium. Prevalence estimates of predicted pathogenic\u00a0COL4A3-Col4a5 variants in a population sequencing database and their implications for alport syndrome. J. Am. Soc. Nephrol. 32, 2273\u20132290 (2021).","DOI":"10.1681\/ASN.2020071065"},{"key":"26291_CR17","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s00467-021-05040-9","volume":"36","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Genotype-phenotype correlations and nephroprotective effects of RAAS inhibition in patients with autosomal recessive Alport syndrome. Pediatr. Nephrol. 36, 2719\u20132730 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"26291_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/cge.12258","volume":"86","author":"C Fallerini","year":"2014","unstructured":"Fallerini, C. et al. Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases. Clin. Genet. 86, 252\u2013257 (2014).","journal-title":"Clin. Genet."},{"key":"26291_CR19","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1093\/ckj\/sfz176","volume":"13","author":"A Matthaiou","year":"2020","unstructured":"Matthaiou, A., Poulli, T. & Deltas, C. Prevalence of clinical, pathological and molecular features of glomerular basement membrane nephropathy caused by COL4A3 or COL4A4 mutations: A systematic review. Clin. Kidney J. 13, 1025\u20131036 (2020).","journal-title":"Clin. Kidney J."},{"key":"26291_CR20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/MNH.0000000000000408","volume":"27","author":"B Sharif","year":"2018","unstructured":"Sharif, B. & Barua, M. Advances in molecular diagnosis and therapeutics in nephrotic syndrome and focal and segmental glomerulosclerosis. Curr. Opin. Nephrol. Hypertens. 27, 194\u2013200 (2018).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"26291_CR21","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ekir.2020.01.008","volume":"5","author":"M Kamura","year":"2020","unstructured":"Kamura, M. et al. Trimerization and genotype-phenotype correlation of COL4A5 mutants in Alport syndrome. Kidney Int. Rep. 5, 718\u2013726 (2020).","journal-title":"Kidney Int. Rep."},{"key":"26291_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000514293","volume":"145","author":"S Isaranuwatchai","year":"2021","unstructured":"Isaranuwatchai, S. et al. Whole-exome sequencing solved over 2-decade kidney disease enigma. Nephron 145, 311\u2013316 (2021).","journal-title":"Nephron"},{"key":"26291_CR23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1681\/ASN.2010010029","volume":"22","author":"TC Jungraithmayr","year":"2011","unstructured":"Jungraithmayr, T. C. et al. Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation. J. Am. Soc. Nephrol. 22, 579\u2013585 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"26291_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2215\/CJN.08970719","volume":"15","author":"A Uffing","year":"2020","unstructured":"Uffing, A. et al. Recurrence of FSGS after kidney transplantation in adults. Clin. J. Am. Soc. Nephrol. 15, 247\u2013256 (2020).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"26291_CR25","doi-asserted-by":"crossref","unstructured":"Sadowski, C.E., Lovric, S., Ashraf, S., et al. SRNS Study Group. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J. Am. Soc. Nephrol. 26, 1279\u20131289 (2015).","DOI":"10.1681\/ASN.2014050489"},{"key":"26291_CR26","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.kint.2016.10.013","volume":"91","author":"A Bierzynska","year":"2017","unstructured":"Bierzynska, A. et al. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. Kidney Int. 91, 937\u2013947 (2017).","journal-title":"Kidney Int."},{"key":"26291_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jmedgenet-2017-104811","volume":"54","author":"ES Sen","year":"2017","unstructured":"Sen, E. S. et al. Clinical genetic testing using a custom-designed steroid-resistant nephrotic syndrome gene panel: analysis and recommendations. J. Med. Genet. 54, 795\u2013804 (2017).","journal-title":"J. Med. Genet."},{"key":"26291_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2215\/CJN.04120417","volume":"13","author":"JK Warejko","year":"2018","unstructured":"Warejko, J. K. et al. Whole exome sequencing of patients with steroid-resistant nephrotic syndrome. Clin. J. Am. Soc. Nephrol. 13, 53\u201362 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"26291_CR29","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.kint.2018.07.024","volume":"94","author":"O Gribouval","year":"2018","unstructured":"Gribouval, O. et al. Identification of genetic causes for sporadic steroid-resistant nephrotic syndrome in adults. Kidney Int. 94, 1013\u20131022 (2018).","journal-title":"Kidney Int."},{"key":"26291_CR30","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/s10038-021-00912-2","volume":"66","author":"S Ammar","year":"2021","unstructured":"Ammar, S. et al. Next-generation sequencing in patients with familial FSGS: first report of collagen gene mutations in Tunisian patients. J. Hum. Genet. 66, 795\u2013803 (2021).","journal-title":"J. Hum. Genet."},{"key":"26291_CR31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41431-020-00719-3","volume":"29","author":"MC Braunisch","year":"2021","unstructured":"Braunisch, M. C. et al. Identification of disease-causing variants by comprehensive genetic testing with exome sequencing in adults with suspicion of hereditary FSGS. Eur. J. Hum. Genet. 29, 262\u2013270 (2021).","journal-title":"Eur. J. Hum. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26291-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26291-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26291-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T11:15:58Z","timestamp":1673867758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-26291-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["26291"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-26291-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"assertion":[{"value":"22 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"805"}}